GLD Globe Life junior subordinated debentures due 2061 attract incomefocused investors amid rising rate environment The market opportunity NexPoint NREF is chasing Grinds Higher 20260508 ASML ASML Holding Q1 earnings beat expectations despite 156 revenue growth shares fall 182 The key risks discussed in CharltonAria CHARR earnings CHARR Q3 Earnings No Revenue as SPAC Rights Trade Continues VICI Properties Inc VICI Holds Steady Near Support as Sector Weighs Cramer Highlights Market Opportunities and Potential Portfolio Shifts During Morning Meeting Pimco High Income Fund PHK Hovers Near Support Amid Cautious Trading SpaceX IPO Lineup Revealed Goldman Sachs and Morgan Stanley Lead 75 Billion MegaListing China Prepares Humanoid Robots for Workforce as Musk Highlights Competition Paul Tudor Jones Says No Chance Kevin Warsh Would Cut Fed Rates China Urges APEC Cooperation as Commerce Minister Skips Opening Session Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Market Rally Highlights Diverging Stock Performance Over SixWeek Record Run UK PublicSector Pension Funding Under Scrutiny Amid Intergenerational Debate AMX Q1 2026 Earnings EPS Beats Estimates Amid Subscriber Growth and Cost Control TVTX Q1 2026 Earnings EPS Falls Short of Expectations Amid RD Focus HSBC Q1 2026 Earnings Modest EPS Beat Amid Quiet Trading Session CCEP Q4 2018 Earnings Slight EPS Miss Highlights Cost Pressures Upstart Holdings Q1 2026 Earnings EPS Misses Estimates Amid Challenging Lending Environment Canaan Inc Q1 2026 Earnings Deep EPS Miss Signals Continued Headwinds New York Times NYT Holds Steady Near 75 as Digital Subscription Growth Fuels Modest Gains WORK Medical Technology WOK Plunges 28 as Selling Pressure Intensifies Opera Limited OPRA Edges Lower Amid Consolidation Near Resistance Pony AI Shares Advance 219 Testing Key Technical Levels MFS Investment Grade Municipal Trust CXH Edges Lower Amid Steady Trading US Productivity Growth Slows in Q4 as Labor Costs Rise Market Implications GSK Q1 2026 Earnings EPS Surpasses Expectations Amid Solid Operational Performance Vera Therapeutics VERA Edges Higher Testing Resistance Amid Steady Volume